Irfan M Rahim, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 77 W Main St, Hopkinton, MA 01748 Phone: 508-435-5506 |
Ms. Claire Y Price, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 77 W. Main St., Hopkinton, MA 01748 Phone: 508-435-5506 Fax: 508-497-5079 |
Mr. Robert D Basow, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 77 W. Main St., Hopkinton, MA 01748 Phone: 508-435-5506 Fax: 508-497-5079 |
Ms. Faith Decesare, NP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 77 W. Main St., Hopkinton, MA 01748 Phone: 508-435-5506 Fax: 508-497-5079 |
Ms. Stephanie M. Bodor, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 77 W. Main St., Hopkinton, MA 01748 Phone: 508-435-5506 Fax: 508-497-5079 |
Carrie M Davies, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Main Street Pediatrics, 77 West Main Street, Hopkinton, MA 01748 Phone: 508-435-5506 |
Cheryl Ann Kelly, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7 Pheasant Hill Rd, Hopkinton, MA 01748 Phone: 508-259-4755 |
Donna M Joshi, NP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 77 W Main St, Hopkinton, MA 01748 Phone: 508-435-5506 |
Andrew R. Willment, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1 Lumber St Ste 200, Hopkinton, MA 01748 Phone: 508-435-5936 Fax: 508-435-4616 |
News Archive
Every cell has thousands of proteins whose activity and lifetime must be regulated to control the cellular life cycle from cell division to cell death. The heat shock protein Hsp90 plays a key role in this process. It is a so-called chaperone, a quality controller, as it were. It monitors and controls the quality and activity of many important signal proteins and helps them take on the right form. When the cell is exposed to high stress levels from heat or a lack of oxygen, Hsp90 is produced in larger quantities to shield its partner proteins from damage.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Complera, a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
The Louisville Courier-Journal: "Facing a $7 million budget cut, the Indiana University School of Medicine plans to reduce the number of new students next year - a move that will save money but could reduce the number of physicians when the state is already facing a shortage. After several years of ramping up acceptances of new medical students, IU was forced to cut back after Gov. Mitch Daniels recently ordered state-funded universities to reduce their budgets, said Dr. D. Craig Brater, dean of the school.
› Verified 5 days ago